5 Results for "

HeLa-ACE2 cells

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "HeLa-ACE2 cells" in MCE Product Catalog:

Cat. No.: HY-149767
CAS No.: 2882934-64-5
Target:  

SARS-CoV

Research Areas:  

Infection

CMX990 is a SARS-CoV-2 3CL protease inhibitor. The EC90s for inhibiting SARS-CoV-2 were 9.6 nM and 101 nM in human bronchial epithelial cells (HBECs) and HeLa-ACE2 cells, respectively. CMX990 has good ADME and pharmacokinetic properties .
loading...
    loading...
Cat. No.: HY-178160
CAS No.: 1581755-42-1
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

SARS-CoV-2 PLpro-IN-2 (Compound 12) is a highly selective SARS-CoV-2 papain-like protease (PLpro) inhibitor of (IC50=0.06 μM). SARS-CoV-2 PLpro-IN-2 inhibits viral replication and immune evasion. SARS-CoV-2 PLpro-IN-2 exhibits antiviral efficacy in HeLa-ACE2 cells (EC50=2.9 μM). SARS-CoV-2 PLpro-IN-2 is promising for research of COVID-19 .
loading...
    loading...
Cat. No.: HY-157154
CAS No.: 2765433-05-2
Purity:  98.45%
Target:  

SARS-CoV

Research Areas:  

Infection

MAT-POS-e194df51-1 is an orally active, non-covalent and non-peptide SARS-CoV-2 main protease (M pro) inhibitor with an IC50 value of 37nM. MAT-POS-e194df51-1 is cytotoxic with EC50 values of 64 nM and 126 nM in A549-ACE2-TMPRSS2 cells and HeLa -ACE2 cells, respectively .
loading...
    loading...
Cat. No.: HY-173411
CAS No.: 3081926-49-7
Target:  

Glycosidase SARS-CoV

Research Areas:  

Infection Inflammation/Immunology

DNJ-20 is an α-glucosidase inhibitor (IC50: 55.3 μg/mL). DNJ-20 has broad-spectrum anti-SARS-CoV-2 activity. DNJ-20 inhibits the correct processing of viral glycoproteins by interfering with the endoplasmic reticulum-associated glycoprotein folding process (ERQC), thereby blocking the formation and infection of viral particles. DNJ-20 has IC50 values up to 1.49 uM against several SARS-CoV-2 variants, as well as HCoV-229E and HCoV-0C43。DNJ-20 can be used for pan-coronavirus research .
loading...
    loading...
Cat. No.: HY-184171
CAS No.: 2883773-06-4
Target:  

SARS-CoV Virus Protease

Research Areas:  

Infection

mCMX110 is an orally active SARS-CoV-2 main protease inhibitor with an IC50 of 35 nM. mCMX110 inhibits SARS-CoV-2 infection. SARS-CoV-2 mCMX110 can be used for the research of SARS-CoV-2 infection .
loading...
    loading...